-
5 days ago | 
pharmaceuticalcommerce.com | Don Tracy
FDA chief Martin Makary sets June deadline for genAI rolloutFDA Commissioner Martin Makary has set a June 30, 2025 deadline for full agency-wide rollout of generative AI to streamline scientific reviews and reduce bureaucratic workload, amid concerns about whether the technology can offset recent staffing cuts under HHS Secretary Robert F.
-
1 week ago | 
pharmaceuticalcommerce.com | Don Tracy
J&J survey finds pace of oncology innovation is overwhelming physiciansA recent J&J survey reveals that oncologists are overwhelmed by the rapid pace of oncology innovation, highlighting the need for additional support and continuing medical education to help them keep up with new treatments and guidelines. Biotech is guessing how Vinay Prasad might change the FDA.
-
1 week ago | 
pharmaceuticalcommerce.com | Don Tracy
In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state of the market, the anticipated growth of the pipeline, and the critical steps needed to ensure long-term sustainability, Gregory highlighted both the transformative potential of these therapies and the systemic challenges that must be addressed.
-
1 week ago | 
pharmaceuticalcommerce.com | Don Tracy
Deerfield secures more than $600M for its next biotech venture fundDeerfield Management has raised over $600 million for its third biotech venture fund to invest in early-stage healthcare companies, leveraging its NYC-based Cure campus and academic partnerships amid a broader industry shift toward larger, more selective funding rounds. The Hardest Job in Biopharma?
-
2 weeks ago | 
pharmaceuticalcommerce.com | Don Tracy
The second day of Asembia’s AXS25 Summit featured a session that addressed a distinct set of challenges facing the pharmaceutical industry. Titled “Beyond the Headlines: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes,” the discussion highlighted how evolving global instability, policy shifts, and supply chain vulnerabilities are reshaping access and strategy within the US healthcare system.
-
2 weeks ago | 
pharmaceuticalcommerce.com | Don Tracy
In an interview with Pharmaceutical Commerce, Will Pih, co-founder, Two Labs, shared insights from his recent panel discussion on “Economics and Specialty Pharmacy for Rare Diseases: Challenges and Opportunities.” The conversation explored the growing complexities of delivering care in the rare disease space, particularly as specialty pharmacies and pharmaceutical manufacturers navigate high drug costs, small patient populations, and an evolving regulatory landscape.
-
2 weeks ago | 
pharmaceuticalcommerce.com | Don Tracy
In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state of the market, the anticipated growth of the pipeline, and the critical steps needed to ensure long-term sustainability, Gregory highlighted both the transformative potential of these therapies and the systemic challenges that must be addressed.
-
2 weeks ago | 
pharmaceuticalcommerce.com | Don Tracy
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted the rapid growth of specialty pharmaceuticals—now comprising over half of the total market—and examined critical industry developments ranging from biosimilar uptake and GLP-1 drug disruption to persistent challenges like retail pharmacy closures and drug shortages.
-
2 weeks ago | 
pharmaceuticalcommerce.com | Don Tracy
In an interview with Pharmaceutical Commerce, Chip Parkinson, the new CEO of Gift Health, shared his perspective on stepping into the role and the evolving challenges and opportunities across the healthcare landscape. Drawing on a diverse background that spans manufacturers, payers, and employer consulting, Parkinson discussed how his new position places him in closer contact with patients and prescribers than ever before.
-
2 weeks ago | 
pharmaceuticalcommerce.com | Don Tracy
As the healthcare industry sharpens its focus on patient-centered care, addressing social determinants of health, health equity, and literacy has become more critical than ever—particularly for individuals with chronic and rare conditions. During the "Speaking Health and Human: Bridging the Gap to Quality Patient Care" session, Tiara Green will join industry leaders to explore how barriers to access, education, and navigation of the healthcare system directly influence patient outcomes.
